rbIFN-λ

A recombinant cytokine.

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Experimental

Supporting references

Contradictory references

AI-suggested references

Clinical trials

rbIFN-λ is a recombinant form of bovine interferon lambda 3 (GenBank HQ317919.1) (Quintana et al., 2018).

Recombinant bovine interferon lambda 3; Recombinant bovine interleukin 28B; Recombinant bovine IL28B

Link	Tested on	Impact factor	Notes	Publication date
Bovine Interferon Lambda Is a Potent Antiviral Against SARS-CoV-2 Infection in vitro Protein factor In vitro	Vero E6 cells; human peripheral blood mononuclear cells	2.25	Manifests anti-SARS-CoV-2 activity without inflammatory side effects in vitro.	Nov/03/2020